Sector ETFs — End-of-Day Verdict
NO ACTION - 0 ACQUIRE, 0 DISPOSE, 0 ANTICIPATE - plus 1 MANDATED WITHDRAWAL (UFO). Six names cleared the conviction floor, the widest bullish board in five weeks, and not one cleared the economics bar the book itself used to admit UFO a session earlier. The three highest-conviction prints are all the SAME trade - the Moderna/Merck melanoma readout (healthcare +3.5%, best day since April 2025, record sector high) plus the Treasury's expanded 10-30y buyback (gold to a two-month high) - bought after it happened: XLV (adj 90) closed AT its 52-week high with RSI 75.4, 1.39 ATR past a buy-stop the market has already run through, and its own Est_12W sits 2.09% BELOW the close (SE-2 on both legs) = 0.15x at the real price; IBB (adj 82) closed AT its 52-week high with RSI 80.4 after +6.58%, risking 12.75% to make 1.69% = 0.13x; GLD (adj 83) has a NEGATIVE four-week estimate (vs a close). XLF (adj 66) is the honest near-miss - best economics on the board at 1.57x with a genuine 1.16-ATR stop and the L1-favoured PullbackBuy_VWAP family, three of four written re-arm legs now PASS, and it is declined on leg 3 alone (entry = the close exactly), with Est_12W below entry for a third session. XLP (adj 83, first STRONG BUY of the run, SE-2 clear for the first time) is declined a third time on a 0.64-ATR stop inside one ordinary session's range, on the family whose measured stop_first is 0.667. XLY has the best-BUILT order in the book (1.07-ATR stop, no chase) and is still declined on a negative Est_4W. SOXX prints the highest-conviction BEARISH read in the book (FailedBreakout_Down_20D, conv 71, -2.21%, Est_12W -5.78%) with SMH collapsing -> 42 in two sessions - the rotation read the gauge exists to produce, with NVIDIA six sessions out. HONEST ACCOUNTING: yesterday's slot-ineligible decline on IBB at COST 7.23%; the same count rule saved 7.06% on SOXX and 6.4% on SMH - net roughly flat with enormous variance, and it demonstrably cannot distinguish a noise flip from a catalyst ignition (systemic finding #2).
Recommendations
0 to acquire · 0 to dispose
| Ticker | Name | Close | Action | Action Price Where to act — a buy-limit on a pullback or a buy-stop above resistance, not the current price. Sanity-check vs Close: on a held name, an action price stranded above the close means the queued level was set when the stock was higher — stale, awaiting reprice. | Stop The risk-defined exit, set below the entry for a long (~1.2–1.8×ATR). A held long whose Stop sits at/above the Close is already below its stop — a stale box awaiting reprice. | 1wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. | 4wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. | 12wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. | Rationale |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR S&P Biotech ETF | 169.55 | WATCH | 169.55 | 160.10 | 168.99 (-0.3%) | 171.52 (+1.2%) | 175.50 (+3.5%) | Biotech jumped 5.9% to a fresh 52-week high on the Moderna/Merck trial win; if this position is held it is a clear hold, not a trim - the gain is not yet large enough to trigger our profit-taking rule, no deterioration warning has printed, and the one-year outlook is still above today's price. We are raising the protective stop to lock in more of the move. Detail: BRANCH-CONDITIONAL - portfolio JSON shows (ground truth = FLAT, 08-07 card effectively SKIPPED); on the instructed branch @. On that branch: + / +8.70% = in one session; gain 2.87 ATR, just UNDER the 3.00-ATR arm threshold, Exit_Warning blank, so ADR-0012 cannot arm and no tick can fire. Est_12W = +3.51% above the close, so L2 does not fire. Close is / 8.6% clear of the stop. The AVOID/ReversalDown_Overbought print resolves to [HOLD] in Signal_Rationale and its Action_Rationale reads 'Flat; do not open (long-only)' - a don't-buy-here print, not a sell; pillars remain constructive (Trend 89, EMA20>EMA50>EMA200). TRAIL-RAISE -> (close - 2.0x ATR), closing basis, never widened; the model's Stop_Price is a short-side level and is discarded. FOUR ADR-0019 cards still need a human: trade buy/skip for 07-30 IBB, 08-06 IBB, 08-07 XBI, and trade skip AIQ 08-07. · news |
Outcome & track record